Day: October 3, 2023

As the U.S. government seemed headed for a possible shutdown last week, cybersecurity firms began picking up on an alarming trend: a spike in cyberattacks targeting government agencies and the U.S. defense industry.

It has some analysts concerned that U.S. adversaries and criminal hackers might have been preparing to take advantage of weaker-than-usual cybersecurity if lawmakers had not been able to reach a deal to keep U.S. agencies open past September 30.

Check Point Software last week said it had detected an 18% increase in cyberattacks against U.S. agencies and U.S. defense companies during the previous 30 days, compared with weekly averages for the first half of the year.

The attacks, according to Check Point, focused on using malware programs designed to steal information and credentials, as well as a focus on exploiting known vulnerabilities.

A second cybersecurity company, Trellix, told VOA that it too saw “a significant spike” in ransomware attacks on U.S. government agencies over the past 30 days.

Trellix attributed 45% of the malicious cyber activity to Royal ransomware, which previously had been used to target a variety of U.S. manufacturing, health care and education sectors.

Agencies would be affected

A surge in the use of Royal ransomware earlier this year prompted the FBI and the Cybersecurity and Infrastructure Security Agency (CISA) to issue an advisory this past March. And some cybersecurity analysts have linked Royal ransomware to Russian cybercriminals.

As for the recent spike in attacks, using Royal and other malware, analysts are concerned.

“I can’t state this is related to the impending shutdown,” Patrick Flynn, head of the Advanced Programs Group at Trellix, told VOA via email. “But one could speculate it probably has something to do with it.”

Concerns

While refusing to comment directly on the pace of cyberattacks as it related to the potential shutdown, U.S. government agencies did express concern.

“[The] Cybersecurity and Infrastructure Security Agency’s (CISA) capacity to provide timely and actionable guidance to help partners defend their networks would be degraded,” the Department of Homeland Security said in a fact sheet before the shutdown was averted.

“CISA would also be forced to suspend both physical and cybersecurity assessments for government and industry partners, including election officials as well as target rich, cyber poor sectors like water, K-12, and health care, which are prime targets for ransomware,” it added.

DHS did say that had there been a shutdown, some of its employees who specialize in cybersecurity would have been required to work without pay.

While not commenting directly on the question of cybersecurity, the FBI told VOA in a statement that some of its personnel would also have been required to work in the case of a shutdown to support bureau activities that “involve protecting life and property.”

For now, some of those fears have been put aside after lawmakers agreed on a bill that will fund the U.S. government until November 17.

But if ongoing talks on legislation to fully fund the government for the coming year stall, it could again put U.S. government networks in the crosshairs.

Attacks seem part of trend

Not all cybersecurity analysts are convinced a government shutdown would make the U.S. more vulnerable to cyberattacks.

Trellix told VOA that while malicious cyber activity spiked in the month leading up to passage of the temporary funding bill, the attacks seemed to be part of a larger, months-long trend that has seen cyber actors increasingly target governments across the globe.

Other cybersecurity firms caution that other recent U.S. government shutdowns, including those in 2013 and in late 2018 to early 2019, have not led to a jump in attacks.

“Mandiant hasn’t historically seen any upward trends of cyberattacks tied to government shutdown,” said Ben Read, the head of cyber espionage analysis at Mandiant-Google Cloud.
…

Meta is proposing to offer European users subscription-based versions of Instagram and Facebook if they would rather not be tracked for ads, a source said on Tuesday.

The idea, first reported by the Wall Street Journal, comes as the social media giant seeks to comply with a growing list of EU regulations designed to curb the power of U.S. big tech.

The company founded by Mark Zuckerberg makes its billions of dollars in profit by offering advertisers highly individualized data on users, but new European regulations and EU court decisions have made that practice harder to do.

The proposal has been put to EU regulators and is another example of big tech companies having to adapt long-held practices to meet oncoming EU rules.

The source close to the matter said subscribers in Europe could pay $10.50 a month for a desktop version of Instagram or Facebook, or $13.50 a month for Instagram on their phones.

Social media platforms have increasingly floated the idea of charging users for access to their sites, whether to comply with data privacy regulations or better guarantee the identity of users.

But the practice would be a major shift for the social media industry that grew exponentially over the past decade on an advertising model that made the site free for users in return for being tracked and seeing highly personalized ads.

The proposal could help meet several regulations, including the Digital Markets Act, which imposes a list of do’s and don’ts on big tech companies in Europe, including a ban on tracking users when they surf other sites if their consent hasn’t been clearly granted.

It also follows the recommendation of the EU’s highest court, which in a July decision said that Meta platform users who declined to be tracked should be offered an ad-free alternative “for an appropriate fee.”

That ruling echoed many previous rulings against Meta and other big tech firms in which the court ruled that the U.S. company must ask for permission to collect large amounts of personal data, striking down various workarounds that Meta had offered.

Meta declined to comment directly on the Wall Street Journal report but said in a statement that it still “believes in the value of free services which are supported by personalized ads.”

“However, we continue to explore options to ensure we comply with evolving regulatory requirements.”

Meta reported second-quarter revenues of $32 billion, of which $31.5 billion came from advertising. Some $7.2 billion of that came from Europe.
…

Belize is developing a pilot project to convert the masses of foul-smelling sargassum seaweed swamping its pristine beaches into biofuel, its prime minister said in a statement published by regional Caribbean bloc CARICOM on Tuesday.

Many Caribbean countries depend economically on drawing travelers from around the world to their white sand beaches, but since 2010 heaps of rotting seaweed have been massing on the shores for reasons scientists do not yet fully understand but suspect are related to climate change.

Floating sargassum provides shelter and food for marine animals but as it washes ashore it can smother ecological habitats and begins to rot, becoming harmful to humans.

Belize Prime Minister John Briceno said in the statement that the $50 million facility, the result of a public-private partnership with German company Variodin, would convert municipal solid waste and sargassum into diesel fuel replacements.

The facility could be scaled up with more financing, he said, adding that it would sign a power purchase agreement for energy generated from the plant.

“The sargassum seaweed invasion [is] causing economic, social and environmental wreckage across Belize and the Caribbean,” CARICOM said, citing estimates that the region spends $120 million a year to collect and dispose of it.

“Removal is a vicious cycle of never-ending sargassum, a cycle that removes the seaweed but also the sand, causing further damage to the coastline,” it said, noting that 24 million tons landed on Caribbean coasts last year — damaging tourism, the fishing industry and people’s health.

Briceno said that while complete mitigation is no longer possible, control is within reach.

“Research conducted shows that conversion of sargassum into the Belize energy mix is a viable solution to the problem,” he said, without detailing when the plant would be operational.
…

A charity group in Zimbabwe is raising funds for a basic product that can be critical for people living with albinism – sunscreen. The group, called “The Noble Hands of Zimbabwe,” released a report in September saying 1 in 3 people with albinism in Zimbabwe die of skin cancer before the age of 40, including children as young as 8. Columbus Mavhunga has more from Harare, Zimbabwe. VOA footage by Blessing Chigwenhembe.
…

A new malaria vaccine approved Monday for use by the World Health Organization could be rolled out in African countries in the next few months, potentially saving hundreds of thousands of children’s lives in the coming years.

The new vaccine, known as R21, was developed by Britain’s Oxford University along with the Serum Institute of India. It is already in use in Ghana and Burkina Faso.

“This new approval for R21 has the potential now that vaccination can occur across sub-Saharan Africa and protect many more children at risk,” said Professor Azra Ghani, an infectious disease epidemiologist at Imperial College London.

“We estimate that if this is rolled out across the continent at the sort of coverage levels that we’ve seen in the implementation study so far, this could avert up to a third of malaria deaths in children under five,” she said.

Dr. Hanna Nohynek, chair of WHO’s Strategic Advisory Group of Experts on Immunization, said the R21 vaccine is expected to close the gap between supply and demand, “enabling broader and possibly unconstrained access. Malaria vaccines introduced widely have the potential of saving tens of thousands of young lives each year,” she told reporters Monday in Geneva.

African trials

The vaccine has been undergoing clinical trials in several African countries. WHO Director-General Tedros Adhanom Ghebreyesus announced the approval at a press conference Monday in Geneva.

“In areas with seasonal transmission, it’s reduced symptomatic cases of malaria by 75% in the 12 months following a three-dose series of the vaccine. A fourth dose given a year after the third was shown to maintain protection,” he said.

In 2021, WHO approved the first malaria vaccine, RTS,S, made by the British pharmaceutical firm GSK.

“As a malaria researcher, I used to dream of the day when we would have a safe and effective vaccine against malaria. Now we have two,” Tedros told reporters.

WHO officials said there is little difference in the effectiveness of the two vaccines. However, the new R21 vaccine is cheaper to make, at around $2 to $4 a dose, with each patient needing four doses. That adds up to about half the cost of the RTS,S vaccine.

The new vaccine can also be made in much greater volumes. The Serum Institute of India is already in line to make 100 million doses a year, with plans to double that output.

Mosquito nets

Experts warn the new vaccine won’t beat malaria on its own, and other preventative measures are needed, including the use of mosquito nets.

“The children in both the vaccine arms and also the control arms [of the trials] were given nets. So, this additional efficacy of the vaccine is in the presence of this really important intervention. The second is something known as chemoprevention, that’s providing drugs to children in high-risk areas where malaria is particularly seasonal. And this is mostly in the Sahel region in west Africa,” Ghani told VOA.

Malaria burden

The World Health Organization estimates there were 247 million cases of malaria in 2021, a small increase on the previous year, and around 619,000 deaths. Ninety-five percent of cases and deaths are in Africa, and most deaths are in children under 5.

“We do hope that by introducing this new vaccine, we can really make a dent in this and get us back on track to the goals which were set by the WHO to reduce malaria by 90% by 2030,” Ghani added.

Dengue fever

WHO also approved a new vaccine Monday against dengue fever, another mosquito-borne disease common in tropical Latin American and Asian countries.

The drug, made by the Japanese multinational firm Takeda, was about 84% effective in clinical trials in preventing people from being hospitalized.
…

New technologies are giving bionic hands some of the more complex features of human hands. Genia Dulot reports on a California company that is using touch feedback to give users a sense of the objects they are holding or interacting with
…

The Nobel Prize in physics was awarded Tuesday to three scientists who look at electrons in atoms during the tiniest of split seconds.

Pierre Agostini of The Ohio State University in the U.S.; Ferenc Krausz of the Max Planck Institute of Quantum Optics and Ludwig Maximilian University of Munich in Germany; and Anne L’Huillier of Lund University in Sweden won the award.

Their experiments “have given humanity new tools for exploring the world of electrons inside atoms and molecules,” according to the Royal Swedish Academy of Sciences, which announced the prize in Stockholm. They “have demonstrated a way to create extremely short pulses of light that can be used to measure the rapid processes in which electrons move or change energy.”

At the moment, this science is about understanding our universe rather than practical applications, but the hope is that it will eventually lead to better electronics and disease diagnosis.

“Attosecond science allows us to address fundamental questions such as the time scale of the photoelectric effect for which Einstein, Albert Einstein, received the Nobel Prize in physics in 1921,” according to Eva Olsson, chair of the Nobel Committee for Physics.

The Nobel Prizes carry a cash award of 11 million Swedish kronor ($1 million). The money comes from a bequest left by the prize’s creator, Swedish inventor Alfred Nobel, who died in 1896.

Last year, three scientists jointly won the physics prize for proving that tiny particles could retain a connection with each other even when separated. The phenomenon was once doubted but is now being explored for potential real-world applications such as encrypting information.

The physics prize comes a day after Hungarian-American Katalin Karikó and American Drew Weissman won the Nobel Prize in medicine for discoveries that enabled the creation of mRNA vaccines against COVID-19.

Nobel announcements will continue with the chemistry prize on Wednesday and the literature prize on Thursday. The Nobel Peace Prize will be announced on Friday and the economics award on Oct. 9.

The laureates are invited to receive their awards at ceremonies on Dec. 10, the anniversary of Nobel’s death. The prestigious peace prize is handed out in Oslo, according to his wishes, while the other award ceremony is held in Stockholm.
…

The World Health Organization on Monday announced the recommendation of a second malaria vaccine, with the aim of giving countries a cheaper and more readily available option to tackle the deadly disease.

Developed by Oxford University with the help of the Serum Institute of India, the new vaccine, known as R-21, will be rolled out in some African countries early next year, and expand into other countries later in 2024, according to WHO chief Tedros Adhanom Ghebreyesus.

Research that has not yet undergone the usual process of scientific review suggests the three-dose vaccine to be around 75% effective. Boosters would be available for continued protection.

“Almost exactly two years ago, WHO recommended the broad use of the world’s first malaria vaccine called RTS,S” also known as Mosquirix, Tedros told a briefing in Geneva.

Developed by British pharmaceutical GSK, Mosquirix requires four doses, is only about 30% effective, and fades within months. The WHO says there is not enough data available to confirm whether the newly developed Oxford vaccine will be more effective.

The Serum Institute has said it could produce 200 million doses of the R-21 vaccine per year, while GSK is able to produce only 15 million doses of Mosquirix annually.

The aim of widespread rollout of the vaccine would be to significantly curb infection rates and spread of the disease. However, experts have urged the public not to see vaccines as a replacement for other preventative measures, such as bed nets and the spraying of insecticides.

The WHO also issued a recommendation on a Takeda Pharmaceuticals-produced vaccine against dengue, a disease prevalent in subtropical climates which, like malaria, is spread by mosquitoes.

Takeda Pharmaceuticals’ vaccine was shown to be effective in all four stereotypes of the virus in previously infected individuals, but it showed a lower performance in some stereotypes of people not previously infected.

Some information for this report was provided by The Associated Press and Reuters. 
…